Joanne Khabsa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Joanne Khabsa has a total of 325 co-authors. Here are the top co-authors by number of shared publications:
- Elie Antoine Akl
Department of Internal Medicine, American University of Beirut, Beirut, Lebanon
28 shared publications - Holger Jens Schünemann
Clinical Epidemiology and Research Center (CERC), Humanitas University & Humanitas Research Hospital, Milan, Italy
10 shared publications Peter Tugwell
Bruyère Health Research Institute, University of Ottawa; School of Epidemiology and Public Health, University of Ottawa; Ottawa Hospital Research Institute, Clinical Epidemiology Program; and Department of Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada (P.T.)
10 shared publications- Jennifer Petkovic
University of Ottawa Ottawa Ontario Canada
7 shared publications - Vivian Welch
University of Ottawa
6 shared publications - Assem M. Khamis
Wolfson Palliative Care Research Centre, Hull York Medical School, University of Hull, Hull, UK
5 shared publications
Latest Publications
- 30 June 2026
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 179 (8) , 1169-1176
Reporting Interest-Holder Engagement in Practice Guidelines: The RIGHT-MuSE Checklist
As part of the development of practice guidelines, developers need to systematically engage relevant interest-holder groups. The Reporting Items for practice Guidelines in HealThcare (RIGHT) checklist for reporting practice guidelines lacks detailed guidance on how to report the engagement process. To develop a standardized checklist for reporting interest-holder engagement in practice guidelines, named the RIGHT-MuSE checklist. The development process followed the methods recommended by the Enhancing the QUAlity and Transparency Of health Research (EQUATOR) Network, as well as lessons learned from the development of the RIGHT statement and its extensions. Key steps included developing the protocol, registering the project, establishing a working group, conducting background work, generating an initial list of items, conducting a consensus survey, holding panel discussions, and creating the final RIGHT-MuSE checklist and an accompanying explanation and elaboration document. International collaboration. 25 panelists from various guideline development interest-holder groups. Consensus agreement on checklist items. The final RIGHT-MuSE checklist consists of 11 items covering the guidance used, methods of engagement, characteristics of interest-holders, evaluation of engagement, and management of conflicts of interest. The checklist is supplemented with a glossary of key terms and detailed explanations for each item to facilitate its use. The RIGHT-MuSE checklist has not been evaluated in a broader context or widely applied in real-world guideline development processes. Guideline developers can use the RIGHT-MuSE checklist to comprehensively report on interest-holder engagement. The Vincent and Lily Woo Foundation.
- 30 June 2026
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 179 (8) , 1169-1176
Reporting Interest-Holder Engagement in Practice Guidelines: The RIGHT-MuSE Checklist
As part of the development of practice guidelines, developers need to systematically engage relevant interest-holder groups. The Reporting Items for practice Guidelines in HealThcare (RIGHT) checklist for reporting practice guidelines lacks detailed guidance on how to report the engagement process. To develop a standardized checklist for reporting interest-holder engagement in practice guidelines, named the RIGHT-MuSE checklist. The development process followed the methods recommended by the Enhancing the QUAlity and Transparency Of health Research (EQUATOR) Network, as well as lessons learned from the development of the RIGHT statement and its extensions. Key steps included developing the protocol, registering the project, establishing a working group, conducting background work, generating an initial list of items, conducting a consensus survey, holding panel discussions, and creating the final RIGHT-MuSE checklist and an accompanying explanation and elaboration document. International collaboration. 25 panelists from various guideline development interest-holder groups. Consensus agreement on checklist items. The final RIGHT-MuSE checklist consists of 11 items covering the guidance used, methods of engagement, characteristics of interest-holders, evaluation of engagement, and management of conflicts of interest. The checklist is supplemented with a glossary of key terms and detailed explanations for each item to facilitate its use. The RIGHT-MuSE checklist has not been evaluated in a broader context or widely applied in real-world guideline development processes. Guideline developers can use the RIGHT-MuSE checklist to comprehensively report on interest-holder engagement. The Vincent and Lily Woo Foundation.
- Open Access
- 18 February 2026
- Published by Wiley in Journal of Evaluation in Clinical Practice
- Vol. 32 (1) , e70375
Principles and Strategies for Interest‐Holder Engagement in Health Guideline Development
Rationale: Guidelines are statements or recommendations that help interest‐holders make decisions about clinical care or health policy. Engaging a wide range of interest‐holders, such as patients, providers, policymakers and members of the public in the guideline development process can help ensure that guidelines are fit‐for‐purpose. The MuSE Consortium is developing guidance for the engagement of interest‐holders throughout the guideline development process in the form of an extension of the Guidelines International Network (GIN)‐McMaster Guideline Development Checklist (GDC). Aims and Objectives: The objective of this study is to identify principles and strategies to promote interest‐holder engagement across the guideline development enterprise. Methods: We conducted interviews with 43 individuals from 10 different interest‐holder groups and 15 different countries. We used a framework analysis to thematically analyze findings and identify principles and strategies relevant for engaged guideline development. Results: Guideline development initiatives may better engage interest‐holders by shifting from vertical to horizontal power structures, emphasizing collaboration and shared decision‐making. We identified a need for epistemic justice, promoting fairness and equality in knowledge production and validation, particularly for patients and members of the public. Representation is a crucial key issue, necessitating diverse perspectives in guideline development groups. Strategies include involving interest‐holders early and meaningfully in the guideline development process through governance, setting clear expectations and timelines, and providing fair compensation. Dissemination activities should extend beyond academic publications, empowering all interest‐holders to contribute to activities such as presentations, educational sessions, or social media campaigns. While engagement is desirable, limitations may arise in emergency contexts or resource‐constrained settings. Conclusions: Guideline developers may need to make pragmatic decisions as to who they engage in guideline development and how. Capacity strengthening in low‐ and middle‐income countries may help address current disparities in engagement in guideline development. Future research should explore issues around representativeness of interest‐holders.
- 18 February 2026
- Published by Wiley in Journal of Evaluation in Clinical Practice
- Vol. 32 (1) , e70375
Open AccessPrinciples and Strategies for Interest‐Holder Engagement in Health Guideline Development
Rationale: Guidelines are statements or recommendations that help interest‐holders make decisions about clinical care or health policy. Engaging a wide range of interest‐holders, such as patients, providers, policymakers and members of the public in the guideline development process can help ensure that guidelines are fit‐for‐purpose. The MuSE Consortium is developing guidance for the engagement of interest‐holders throughout the guideline development process in the form of an extension of the Guidelines International Network (GIN)‐McMaster Guideline Development Checklist (GDC). Aims and Objectives: The objective of this study is to identify principles and strategies to promote interest‐holder engagement across the guideline development enterprise. Methods: We conducted interviews with 43 individuals from 10 different interest‐holder groups and 15 different countries. We used a framework analysis to thematically analyze findings and identify principles and strategies relevant for engaged guideline development. Results: Guideline development initiatives may better engage interest‐holders by shifting from vertical to horizontal power structures, emphasizing collaboration and shared decision‐making. We identified a need for epistemic justice, promoting fairness and equality in knowledge production and validation, particularly for patients and members of the public. Representation is a crucial key issue, necessitating diverse perspectives in guideline development groups. Strategies include involving interest‐holders early and meaningfully in the guideline development process through governance, setting clear expectations and timelines, and providing fair compensation. Dissemination activities should extend beyond academic publications, empowering all interest‐holders to contribute to activities such as presentations, educational sessions, or social media campaigns. While engagement is desirable, limitations may arise in emergency contexts or resource‐constrained settings. Conclusions: Guideline developers may need to make pragmatic decisions as to who they engage in guideline development and how. Capacity strengthening in low‐ and middle‐income countries may help address current disparities in engagement in guideline development. Future research should explore issues around representativeness of interest‐holders.
- Open Access
- 28 January 2026
- Published by Wiley in Clinical and Public Health Guidelines
- Vol. 3 (2)
Development of a GIN‐McMaster Checklist Extension for Out‐of‐Hospital Health Guidelines: A Research Protocol
Introduction: The delivery of healthcare in the out‐of‐hospital setting by paramedics, emergency medical technicians, and first responders is informed by various health guidelines that cover a myriad of medical presentations. These guidelines often score poorly on quality assessment tools and do not routinely meet accepted standards for guideline development. To address this, we propose the development of an extension to the Guideline International Network (GIN)‐McMaster Guideline Development Checklist (GDC) to assist developers of health guidelines on out‐of‐hospital care. Methods: The aim of this project are to: (i) identify the current methodologies, approaches and processes used by developers of guidelines on out‐of‐hospital care and determine how they align with the original GIN‐McMaster GDC; (ii) understand the overarching barriers and enablers of guideline development in this setting; (iii) generate a fit‐for‐purpose extension through an iterative consensus‐based approach; and (iv) disseminate this document to target users. Discussion: This protocol outlines the proposed development of an extension to the GIN‐McMaster GDC, designed specifically for developers of health guidelines on out‐of‐hospital care. The development of this extension will be informed by understanding current practices and the determinants that influence guideline development in this setting. This will involve reviewing all items within the original checklist to determine if modifications and/or new items are required.
- 28 January 2026
- Published by Wiley in Clinical and Public Health Guidelines
- Vol. 3 (2)
Open AccessDevelopment of a GIN‐McMaster Checklist Extension for Out‐of‐Hospital Health Guidelines: A Research Protocol
Introduction: The delivery of healthcare in the out‐of‐hospital setting by paramedics, emergency medical technicians, and first responders is informed by various health guidelines that cover a myriad of medical presentations. These guidelines often score poorly on quality assessment tools and do not routinely meet accepted standards for guideline development. To address this, we propose the development of an extension to the Guideline International Network (GIN)‐McMaster Guideline Development Checklist (GDC) to assist developers of health guidelines on out‐of‐hospital care. Methods: The aim of this project are to: (i) identify the current methodologies, approaches and processes used by developers of guidelines on out‐of‐hospital care and determine how they align with the original GIN‐McMaster GDC; (ii) understand the overarching barriers and enablers of guideline development in this setting; (iii) generate a fit‐for‐purpose extension through an iterative consensus‐based approach; and (iv) disseminate this document to target users. Discussion: This protocol outlines the proposed development of an extension to the GIN‐McMaster GDC, designed specifically for developers of health guidelines on out‐of‐hospital care. The development of this extension will be informed by understanding current practices and the determinants that influence guideline development in this setting. This will involve reviewing all items within the original checklist to determine if modifications and/or new items are required.
- Open Access
- 15 January 2026
- Published by Wiley in Cochrane Evidence Synthesis and Methods
- Vol. 4 (1)
Methods of Engaging Interest‐Holders in Healthcare Evidence Syntheses: A Scoping Review
Introduction: Engaging interest‐holders in health care evidence syntheses may make evidence syntheses more relevant, useful, and accessible. However, the best way(s) to engage interest‐holders within the evidence synthesis process remain unknown. A previous scoping review collated 291 publications that reported interest‐holder engagement in evidence syntheses, but conclusions were limited due to poor reporting. In the present scoping review, our aim was to identify and collate up‐to‐date publications focussed on interest‐holder engagement in healthcare evidence syntheses, describe reported methods of engagement, and compare the results with those from the previous review. Methods: We updated a scoping review, following JBI guidance, using a pre‐published protocol that defined all key terminology in this field. We systematically searched five electronic databases (MEDLINE, CINAHL, EMBASE, PsycInfo, and SCOPUS). Searches were conducted from January 2016 to February 2024. Records were imported into Covidence and screened by pairs of independent reviewers, including any publications that reported engagement of interest‐holders in evidence syntheses. We extracted and coded key data relating to the evidence synthesis topic and ACTIVE framework domains (who was engaged, when, and in what way). Two reviewers independently made a judgment of the comprehensiveness of the description of methods of engagement, using a “traffic‐light” system, coding evidence syntheses with comprehensive descriptions as “green,” brief or partial descriptions as “amber,” and those with few details as “red”; disagreements were resolved through discussion. Additional detailed data relating to the engagement methods were extracted from “green” evidence syntheses. Any disagreements were resolved through discussion. Data were synthesized within tables, and narrative summaries were written to provide an overview of key methods of engaging interest‐holders within the identified evidence syntheses. Results: We identified 302 publications published since the previous review. Most (272/302, 90%) reported interest‐holder engagement in a single evidence synthesis; of these, 74% (200/272) engaged patients and/or their carers, while 17% (46/272) engaged other interest‐holders only, and the remainder (26/272, 9.6%) was unclear. Over three‐quarters of the evidence syntheses were conducted either in the United Kingdom, United States, Canada, or Australia (215/272, 79%). Most often (113/272, 42%), interest‐holders were engaged at both the initial (scope and question setting) and final (interpretation of results) review stages (referred to as a “top and tail” approach). Nineteen percent (51/272) were judged to provide a comprehensive (“green”) description of one or more method(s) or approach(es) to engagement in an evidence synthesis, enabling detailed data extraction and description. Most: engaged patients/public members and other interest‐holder groups (30/51, 59%); used a “closed” recruitment strategy (30/51, 59%); engaged interest‐holders during the stage of interpretation of findings (39/51, 76%); had at least one interest‐holder as a co‐author (27/51, 52%). Interest‐holders generally attended meetings at which no formal methods of engagement were used. It was common to engage interest‐holders in multiple activities throughout the review process. Discussion/Conclusion: Our international team from the MuSE consortium has updated a previous scoping review, compiling the latest evidence on interest‐holder engagement in evidence syntheses. We collated 302 publications and described the methods of interest‐holder engagement reported in 51 evidence syntheses that we judged provided the most comprehensive information. Interest‐holders have been involved at all stages of the process, using a wide range of engagement approaches, but with no clear patterns linked to the type or focus of evidence syntheses. Most commonly, patients/public and professional interest‐holders were both engaged, but around one‐quarter of our examples only engaged patients/public members, and a small number only engaged professional interest‐holders. We identified some distinct engagement strategies and have used these to inform a potential decision tool to support the selection of engagement strategies. We propose recommendations in relation to the conduct and reporting of interest‐holder engagement in evidence syntheses and future research to advance this field.
- 15 January 2026
- Published by Wiley in Cochrane Evidence Synthesis and Methods
- Vol. 4 (1)
Open AccessMethods of Engaging Interest‐Holders in Healthcare Evidence Syntheses: A Scoping Review
Introduction: Engaging interest‐holders in health care evidence syntheses may make evidence syntheses more relevant, useful, and accessible. However, the best way(s) to engage interest‐holders within the evidence synthesis process remain unknown. A previous scoping review collated 291 publications that reported interest‐holder engagement in evidence syntheses, but conclusions were limited due to poor reporting. In the present scoping review, our aim was to identify and collate up‐to‐date publications focussed on interest‐holder engagement in healthcare evidence syntheses, describe reported methods of engagement, and compare the results with those from the previous review. Methods: We updated a scoping review, following JBI guidance, using a pre‐published protocol that defined all key terminology in this field. We systematically searched five electronic databases (MEDLINE, CINAHL, EMBASE, PsycInfo, and SCOPUS). Searches were conducted from January 2016 to February 2024. Records were imported into Covidence and screened by pairs of independent reviewers, including any publications that reported engagement of interest‐holders in evidence syntheses. We extracted and coded key data relating to the evidence synthesis topic and ACTIVE framework domains (who was engaged, when, and in what way). Two reviewers independently made a judgment of the comprehensiveness of the description of methods of engagement, using a “traffic‐light” system, coding evidence syntheses with comprehensive descriptions as “green,” brief or partial descriptions as “amber,” and those with few details as “red”; disagreements were resolved through discussion. Additional detailed data relating to the engagement methods were extracted from “green” evidence syntheses. Any disagreements were resolved through discussion. Data were synthesized within tables, and narrative summaries were written to provide an overview of key methods of engaging interest‐holders within the identified evidence syntheses. Results: We identified 302 publications published since the previous review. Most (272/302, 90%) reported interest‐holder engagement in a single evidence synthesis; of these, 74% (200/272) engaged patients and/or their carers, while 17% (46/272) engaged other interest‐holders only, and the remainder (26/272, 9.6%) was unclear. Over three‐quarters of the evidence syntheses were conducted either in the United Kingdom, United States, Canada, or Australia (215/272, 79%). Most often (113/272, 42%), interest‐holders were engaged at both the initial (scope and question setting) and final (interpretation of results) review stages (referred to as a “top and tail” approach). Nineteen percent (51/272) were judged to provide a comprehensive (“green”) description of one or more method(s) or approach(es) to engagement in an evidence synthesis, enabling detailed data extraction and description. Most: engaged patients/public members and other interest‐holder groups (30/51, 59%); used a “closed” recruitment strategy (30/51, 59%); engaged interest‐holders during the stage of interpretation of findings (39/51, 76%); had at least one interest‐holder as a co‐author (27/51, 52%). Interest‐holders generally attended meetings at which no formal methods of engagement were used. It was common to engage interest‐holders in multiple activities throughout the review process. Discussion/Conclusion: Our international team from the MuSE consortium has updated a previous scoping review, compiling the latest evidence on interest‐holder engagement in evidence syntheses. We collated 302 publications and described the methods of interest‐holder engagement reported in 51 evidence syntheses that we judged provided the most comprehensive information. Interest‐holders have been involved at all stages of the process, using a wide range of engagement approaches, but with no clear patterns linked to the type or focus of evidence syntheses. Most commonly, patients/public and professional interest‐holders were both engaged, but around one‐quarter of our examples only engaged patients/public members, and a small number only engaged professional interest‐holders. We identified some distinct engagement strategies and have used these to inform a potential decision tool to support the selection of engagement strategies. We propose recommendations in relation to the conduct and reporting of interest‐holder engagement in evidence syntheses and future research to advance this field.
- 1 January 2026
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 179 (1) , 132-133
Management of Conflicts of Interest in Practice Guidelines: Time to Also Account for Open-Mindedness?
- 1 January 2026
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 179 (1) , 132-133
Management of Conflicts of Interest in Practice Guidelines: Time to Also Account for Open-Mindedness?
- Open Access
- 20 November 2025
- Published by Wiley in Cochrane Evidence Synthesis and Methods
- Vol. 3 (6) , e70057
Introducing a Series of Reviews Assessing Engagement in Evidence Syntheses
- 20 November 2025
- Published by Wiley in Cochrane Evidence Synthesis and Methods
- Vol. 3 (6) , e70057
Open AccessIntroducing a Series of Reviews Assessing Engagement in Evidence Syntheses
- 20 November 2025
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 189, 112061
Guideline organizations' guidance documents paper 5: conflict of interest and funding
- 20 November 2025
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 189, 112061
Guideline organizations' guidance documents paper 5: conflict of interest and funding
- 20 November 2025
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 189, 112066
Guideline organizations' guidance documents paper 9: co-operative approaches
- 20 November 2025
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 189, 112066
Guideline organizations' guidance documents paper 9: co-operative approaches
- 20 November 2025
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 189, 112062
Guideline organizations’ guidance documents paper 7: updating practice guidelines
- 20 November 2025
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 189, 112062
Guideline organizations’ guidance documents paper 7: updating practice guidelines
- 20 November 2025
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 189, 112064
Guideline organizations’ guidance documents paper 6: adaptation of practice guidelines
- 20 November 2025
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 189, 112064
Guideline organizations’ guidance documents paper 6: adaptation of practice guidelines